127 related articles for article (PubMed ID: 24055834)
21. Inhibitory activity of dioxolane purine analogs on wild-type and lamivudine-resistant mutants of hepadnaviruses.
Seignères B; Pichoud C; Martin P; Furman P; Trépo C; Zoulim F
Hepatology; 2002 Sep; 36(3):710-22. PubMed ID: 12198665
[TBL] [Abstract][Full Text] [Related]
22. Antisense therapy of hepatitis B virus infection.
Offensperger WB; Offensperger S; Blum HE
Mol Biotechnol; 1998 Apr; 9(2):161-70. PubMed ID: 9658393
[TBL] [Abstract][Full Text] [Related]
23. Animal models for the study of HBV infection and the evaluation of new anti-HBV strategies.
Zoulim F; Berthillon P; Guerhier FL; Seigneres B; Germon S; Pichoud C; Cheng YC; Trepo C
J Gastroenterol Hepatol; 2002 Dec; 17 Suppl():S460-3. PubMed ID: 12534778
[TBL] [Abstract][Full Text] [Related]
24. [Inhibitory effect of trisodium phosphonoformate (PFA) on duck hepatitis B virus (DHBV) DNA in vivo].
Chen X; Chen H
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Sep; 11(3):277-81. PubMed ID: 15617348
[TBL] [Abstract][Full Text] [Related]
25. [Anti-virus effect of hepatocyte stimulating substance (HSS) on duck hepatitis B virus in vivo].
Chen G; Chen J; Liu D; Zhang X; Zhu C; Li Y; Wang L; Yang Y; Cai G; Han F
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 1997 Dec; 11(4):329-32. PubMed ID: 15617240
[TBL] [Abstract][Full Text] [Related]
26. [Establishment of a method to detect duck hepatitis B virus covalently closed circular DNA based on rolling circle amplification].
Su HL; Wang HM; Ran JY; Wang Z; Li HY; Yang Y; Xu DP; Liu YM
Bing Du Xue Bao; 2014 Jul; 30(4):382-6. PubMed ID: 25272590
[TBL] [Abstract][Full Text] [Related]
27. Inhibitory effect of 9-(2-phosphonylmethoxyethyl)-adenine (PMEA) on human and duck hepatitis B virus infection.
Heijtink RA; De Wilde GA; Kruining J; Berk L; Balzarini J; De Clercq E; Holy A; Schalm SW
Antiviral Res; 1993 Jun; 21(2):141-53. PubMed ID: 8338351
[TBL] [Abstract][Full Text] [Related]
28. Effect and mechanism of methyl helicterate isolated from Helicteres angustifolia (Sterculiaceae) on hepatic fibrosis induced by carbon tetrachloride in rats.
Huang Q; Li Y; Zhang S; Huang R; Zheng L; Wei L; He M; Liao M; Li L; Zhuo L; Lin X
J Ethnopharmacol; 2012 Oct; 143(3):889-95. PubMed ID: 22967666
[TBL] [Abstract][Full Text] [Related]
29. Taraxacum mongolicum extract exhibits a protective effect on hepatocytes and an antiviral effect against hepatitis B virus in animal and human cells.
Jia YY; Guan RF; Wu YH; Yu XP; Lin WY; Zhang YY; Liu T; Zhao J; Shi SY; Zhao Y
Mol Med Rep; 2014 Apr; 9(4):1381-7. PubMed ID: 24481875
[TBL] [Abstract][Full Text] [Related]
30. [Establishment of an in vivo model for duck hepatitis B virus infection using Hubei duckling].
Hu Q; Fang Y; Zhang ZM; Zhang XY; Zhang ZH; Yang DL
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Apr; 22(2):113-5. PubMed ID: 18574531
[TBL] [Abstract][Full Text] [Related]
31. Inhibitory effect of total saponins isolated from Taraphochlamys affinis on duck hepatitis B virus replication.
Lin X; Huang Q; Zhang S; Huang J; Huang R
Zhongguo Zhong Yao Za Zhi; 2012 Feb; 37(3):384-9. PubMed ID: 22568246
[TBL] [Abstract][Full Text] [Related]
32. Anti-hepatitis B virus activity of wogonin in vitro and in vivo.
Guo Q; Zhao L; You Q; Yang Y; Gu H; Song G; Lu N; Xin J
Antiviral Res; 2007 Apr; 74(1):16-24. PubMed ID: 17280723
[TBL] [Abstract][Full Text] [Related]
33. 2',3'-dideoxy-beta-L-5-fluorocytidine inhibits duck hepatitis B virus reverse transcription and suppresses viral DNA synthesis in hepatocytes, both in vitro and in vivo.
Zoulim F; Dannaoui E; Borel C; Hantz O; Lin TS; Liu SH; Trépo C; Cheng YC
Antimicrob Agents Chemother; 1996 Feb; 40(2):448-53. PubMed ID: 8834896
[TBL] [Abstract][Full Text] [Related]
34. Effect of Oenanthe javanica flavone on human and duck hepatitis B virus infection.
Wang WN; Yang XB; Liu HZ; Huang ZM; Wu GX
Acta Pharmacol Sin; 2005 May; 26(5):587-92. PubMed ID: 15842778
[TBL] [Abstract][Full Text] [Related]
35. Antiviral therapy with entecavir combined with post-exposure "prime-boost" vaccination eliminates duck hepatitis B virus-infected hepatocytes and prevents the development of persistent infection.
Miller DS; Boyle D; Feng F; Reaiche GY; Kotlarski I; Colonno R; Jilbert AR
Virology; 2008 Apr; 373(2):329-41. PubMed ID: 18206204
[TBL] [Abstract][Full Text] [Related]
36. Covalently closed circular DNA is the predominant form of duck hepatitis B virus DNA that persists following transient infection.
Le Mire MF; Miller DS; Foster WK; Burrell CJ; Jilbert AR
J Virol; 2005 Oct; 79(19):12242-52. PubMed ID: 16160150
[TBL] [Abstract][Full Text] [Related]
37. Effects of liver growth factors on hepadnavirus replication in chronically infected duck hepatocytes.
Schorr O; Borel C; Trepo C; Zoulim F; Hantz O
J Hepatol; 2006 May; 44(5):842-7. PubMed ID: 16458387
[TBL] [Abstract][Full Text] [Related]
38. [Study on the replication of hepatitis B virus compared with that of duck hepatitis B virus in primary duck hepatocytes].
Yao Y; Tang N; Huang A
Zhonghua Yi Xue Za Zhi; 2001 Oct; 81(19):1157-61. PubMed ID: 11769700
[TBL] [Abstract][Full Text] [Related]
39. Antiviral effect of Phyllanthus nanus ethanolic extract against hepatitis B virus (HBV) by expression microarray analysis.
Lam WY; Leung KT; Law PT; Lee SM; Chan HL; Fung KP; Ooi VE; Waye MM
J Cell Biochem; 2006 Mar; 97(4):795-812. PubMed ID: 16237706
[TBL] [Abstract][Full Text] [Related]
40. Evidence that hepatocyte turnover is required for rapid clearance of duck hepatitis B virus during antiviral therapy of chronically infected ducks.
Fourel I; Cullen JM; Saputelli J; Aldrich CE; Schaffer P; Averett DR; Pugh J; Mason WS
J Virol; 1994 Dec; 68(12):8321-30. PubMed ID: 7966625
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]